Effects of atrial natriuretic peptide after prolonged hypothermic storage of the isolated rat heart

Hitoshi Kanamitsu, Yasuhiro Fujii, Hideya Mitsui, Shunji Sano

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Primary graft failure (PGF) caused by ischemia-reperfusion injury (IRI) is the strongest determinant of perioperative mortality after heart transplantation. Atrial natriuretic peptide (ANP) has been found to reduce the IRI of cardiomyocytes and may be beneficial in alleviating PGF after heart transplantation, although there is a lack of evidence to support this issue. The purpose of this study was to investigate the cardioprotective effects of ANP after prolonged hypothermic storage. For this purpose, an isolated working-heart rat model was used. After the preparation, the hearts were arrested with and stored in an extracellular-based cardioplegic solution at 3-4°C for 6h and followed by 25min of reperfusion. The hearts were divided into four groups (n=7 in each group) according to the timing of ANP administration: Group 1 (in perfusate before storage), Group 2 (in cardioplegia), Group 3 (in reperfusate), and control (no administration of ANP). Left ventricular functional recovery and the incidence of ventricular fibrillation (VF) were compared. ANP administration at the time of reperfusion improved the percent recovery of left ventricular developed pressure (control, 45.5±10.2; Group 1, 47.4±8.8; Group 2, 45.3±12 vs. Group 3, 76.3±7; P

Original languageEnglish
Pages (from-to)1003-1008
Number of pages6
JournalArtificial Organs
Volume37
Issue number11
DOIs
Publication statusPublished - Nov 2013

Fingerprint

Atrial Natriuretic Factor
Rats
Heart Transplantation
Reperfusion Injury
Grafts
Reperfusion
Cardioplegic Solutions
Transplantation (surgical)
Transplants
Recovery
Induced Heart Arrest
Pressure control
Ventricular Fibrillation
Ventricular Pressure
Cardiac Myocytes
Natriuretic Peptides
Control Groups
Mortality
Incidence

Keywords

  • Atrial natriuretic peptide
  • Hypothermic storage
  • Myocardial reperfusion injury
  • Primary graft failure

ASJC Scopus subject areas

  • Biomaterials
  • Biomedical Engineering
  • Bioengineering
  • Medicine (miscellaneous)

Cite this

Effects of atrial natriuretic peptide after prolonged hypothermic storage of the isolated rat heart. / Kanamitsu, Hitoshi; Fujii, Yasuhiro; Mitsui, Hideya; Sano, Shunji.

In: Artificial Organs, Vol. 37, No. 11, 11.2013, p. 1003-1008.

Research output: Contribution to journalArticle

Kanamitsu, Hitoshi ; Fujii, Yasuhiro ; Mitsui, Hideya ; Sano, Shunji. / Effects of atrial natriuretic peptide after prolonged hypothermic storage of the isolated rat heart. In: Artificial Organs. 2013 ; Vol. 37, No. 11. pp. 1003-1008.
@article{97fc223f279c40a888ed4407f0e811fb,
title = "Effects of atrial natriuretic peptide after prolonged hypothermic storage of the isolated rat heart",
abstract = "Primary graft failure (PGF) caused by ischemia-reperfusion injury (IRI) is the strongest determinant of perioperative mortality after heart transplantation. Atrial natriuretic peptide (ANP) has been found to reduce the IRI of cardiomyocytes and may be beneficial in alleviating PGF after heart transplantation, although there is a lack of evidence to support this issue. The purpose of this study was to investigate the cardioprotective effects of ANP after prolonged hypothermic storage. For this purpose, an isolated working-heart rat model was used. After the preparation, the hearts were arrested with and stored in an extracellular-based cardioplegic solution at 3-4°C for 6h and followed by 25min of reperfusion. The hearts were divided into four groups (n=7 in each group) according to the timing of ANP administration: Group 1 (in perfusate before storage), Group 2 (in cardioplegia), Group 3 (in reperfusate), and control (no administration of ANP). Left ventricular functional recovery and the incidence of ventricular fibrillation (VF) were compared. ANP administration at the time of reperfusion improved the percent recovery of left ventricular developed pressure (control, 45.5±10.2; Group 1, 47.4±8.8; Group 2, 45.3±12 vs. Group 3, 76.3±7; P",
keywords = "Atrial natriuretic peptide, Hypothermic storage, Myocardial reperfusion injury, Primary graft failure",
author = "Hitoshi Kanamitsu and Yasuhiro Fujii and Hideya Mitsui and Shunji Sano",
year = "2013",
month = "11",
doi = "10.1111/aor.12120",
language = "English",
volume = "37",
pages = "1003--1008",
journal = "Artificial Organs",
issn = "0160-564X",
publisher = "Wiley-Blackwell",
number = "11",

}

TY - JOUR

T1 - Effects of atrial natriuretic peptide after prolonged hypothermic storage of the isolated rat heart

AU - Kanamitsu, Hitoshi

AU - Fujii, Yasuhiro

AU - Mitsui, Hideya

AU - Sano, Shunji

PY - 2013/11

Y1 - 2013/11

N2 - Primary graft failure (PGF) caused by ischemia-reperfusion injury (IRI) is the strongest determinant of perioperative mortality after heart transplantation. Atrial natriuretic peptide (ANP) has been found to reduce the IRI of cardiomyocytes and may be beneficial in alleviating PGF after heart transplantation, although there is a lack of evidence to support this issue. The purpose of this study was to investigate the cardioprotective effects of ANP after prolonged hypothermic storage. For this purpose, an isolated working-heart rat model was used. After the preparation, the hearts were arrested with and stored in an extracellular-based cardioplegic solution at 3-4°C for 6h and followed by 25min of reperfusion. The hearts were divided into four groups (n=7 in each group) according to the timing of ANP administration: Group 1 (in perfusate before storage), Group 2 (in cardioplegia), Group 3 (in reperfusate), and control (no administration of ANP). Left ventricular functional recovery and the incidence of ventricular fibrillation (VF) were compared. ANP administration at the time of reperfusion improved the percent recovery of left ventricular developed pressure (control, 45.5±10.2; Group 1, 47.4±8.8; Group 2, 45.3±12 vs. Group 3, 76.3±7; P

AB - Primary graft failure (PGF) caused by ischemia-reperfusion injury (IRI) is the strongest determinant of perioperative mortality after heart transplantation. Atrial natriuretic peptide (ANP) has been found to reduce the IRI of cardiomyocytes and may be beneficial in alleviating PGF after heart transplantation, although there is a lack of evidence to support this issue. The purpose of this study was to investigate the cardioprotective effects of ANP after prolonged hypothermic storage. For this purpose, an isolated working-heart rat model was used. After the preparation, the hearts were arrested with and stored in an extracellular-based cardioplegic solution at 3-4°C for 6h and followed by 25min of reperfusion. The hearts were divided into four groups (n=7 in each group) according to the timing of ANP administration: Group 1 (in perfusate before storage), Group 2 (in cardioplegia), Group 3 (in reperfusate), and control (no administration of ANP). Left ventricular functional recovery and the incidence of ventricular fibrillation (VF) were compared. ANP administration at the time of reperfusion improved the percent recovery of left ventricular developed pressure (control, 45.5±10.2; Group 1, 47.4±8.8; Group 2, 45.3±12 vs. Group 3, 76.3±7; P

KW - Atrial natriuretic peptide

KW - Hypothermic storage

KW - Myocardial reperfusion injury

KW - Primary graft failure

UR - http://www.scopus.com/inward/record.url?scp=84888039354&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84888039354&partnerID=8YFLogxK

U2 - 10.1111/aor.12120

DO - 10.1111/aor.12120

M3 - Article

C2 - 23826817

AN - SCOPUS:84888039354

VL - 37

SP - 1003

EP - 1008

JO - Artificial Organs

JF - Artificial Organs

SN - 0160-564X

IS - 11

ER -